Neil Stahl News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Neil stahl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Neil Stahl Today - Breaking & Trending Today
Synovus Financial Corp lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,594 shares of the biopharmaceutical company’s stock after selling 91 shares during […] ....
Banque Cantonale Vaudoise reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 42.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,588 shares of the biopharmaceutical company’s stock after selling 2,688 shares during the period. Banque […] ....
Raymond James upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a market perform rating to an outperform rating in a report released on Friday morning, MarketBeat reports. The brokerage currently has $950.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued reports about the company. Morgan Stanley […] ....
Forsta AP Fonden decreased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,300 shares of the biopharmaceutical company’s stock after selling 200 shares during […] ....
Cutter & CO Brokerage Inc. lessened its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.2% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 8,121 shares of the biopharmaceutical company’s stock after selling 20 shares during the quarter. Regeneron Pharmaceuticals comprises about 1.7% of Cutter & CO Brokerage Inc.’s investment portfolio, […] ....